Cendakimab meets primary endpoints in eosinophilic oesophagitis Presented ByProf. Alain Schoepfer, University of Lausanne, Switzerland TrialPhase 3 ConferenceUEGW 2024 TypePeer-reviewed article 28 November 2024 11:18